4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Compromised DNA repair is responsible for diabetes‐associated fibrosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diabetes‐associated organ fibrosis, marked by elevated cellular senescence, is a growing health concern. Intriguingly, the mechanism underlying this association remained unknown. Moreover, insulin alone can neither reverse organ fibrosis nor the associated secretory phenotype, favoring the exciting notion that thus far unknown mechanisms must be operative. Here, we show that experimental type 1 and type 2 diabetes impairs DNA repair, leading to senescence, inflammatory phenotypes, and ultimately fibrosis. Carbohydrates were found to trigger this cascade by decreasing the NAD +/ NADH ratio and NHEJ‐repair in vitro and in diabetes mouse models. Restoring DNA repair by nuclear over‐expression of phosphomimetic RAGE reduces DNA damage, inflammation, and fibrosis, thereby restoring organ function. Our study provides a novel conceptual framework for understanding diabetic fibrosis on the basis of persistent DNA damage signaling and points to unprecedented approaches to restore DNA repair capacity for resolution of fibrosis in patients with diabetes.

          Abstract

          Persistent DNA damage due to metabolic reprogramming underlies the senescence and fibrotic phenotypes of diabetes patients.

          Related collections

          Most cited references95

          • Record: found
          • Abstract: found
          • Article: not found

          Persistent DNA damage signaling triggers senescence-associated inflammatory cytokine secretion

          Cellular senescence suppresses cancer by stably arresting the proliferation of damaged cells1. Paradoxically, senescent cells also secrete factors that alter tissue microenvironments2. The pathways regulating this secretion are unknown. We show that damaged human cells develop persistent chromatin lesions bearing hallmarks of DNA double-strand breaks (DSBs), which initiate increased secretion of inflammatory cytokines such as interleukin-6 (IL-6). Cytokine secretion occurred only after establishment of persistent DNA damage signaling, usually associated with senescence, not after transient DNA damage responses (DDR). Initiation and maintenance of this cytokine response required the DDR proteins ATM, NBS1 and CHK2, but not the cell cycle arrest enforcers p53 and pRb. ATM was also essential for IL-6 secretion during oncogene-induced senescence and by damaged cells that bypass senescence. Further, DDR activity and IL-6 were elevated in human cancers, and ATM-depletion suppressed the ability of senescent cells to stimulate IL-6-dependent cancer cell invasiveness. Thus, in addition to orchestrating cell cycle checkpoints and DNA repair, a novel and important role of the DDR is to allow damaged cells to communicate their compromised state to the surrounding tissue.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Human CtIP promotes DNA end resection.

            In the S and G2 phases of the cell cycle, DNA double-strand breaks (DSBs) are processed into single-stranded DNA, triggering ATR-dependent checkpoint signalling and DSB repair by homologous recombination. Previous work has implicated the MRE11 complex in such DSB-processing events. Here, we show that the human CtIP (RBBP8) protein confers resistance to DSB-inducing agents and is recruited to DSBs exclusively in the S and G2 cell-cycle phases. Moreover, we reveal that CtIP is required for DSB resection, and thereby for recruitment of replication protein A (RPA) and the protein kinase ATR to DSBs, and for the ensuing ATR activation. Furthermore, we establish that CtIP physically and functionally interacts with the MRE11 complex, and that both CtIP and MRE11 are required for efficient homologous recombination. Finally, we reveal that CtIP has sequence homology with Sae2, which is involved in MRE11-dependent DSB processing in yeast. These findings establish evolutionarily conserved roles for CtIP-like proteins in controlling DSB resection, checkpoint signalling and homologous recombination.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Telomerase mutations in families with idiopathic pulmonary fibrosis.

              Idiopathic pulmonary fibrosis is progressive and often fatal; causes of familial clustering of the disease are unknown. Germ-line mutations in the genes hTERT and hTR, encoding telomerase reverse transcriptase and telomerase RNA, respectively, cause autosomal dominant dyskeratosis congenita, a rare hereditary disorder associated with premature death from aplastic anemia and pulmonary fibrosis. To test the hypothesis that familial idiopathic pulmonary fibrosis may be caused by short telomeres, we screened 73 probands from the Vanderbilt Familial Pulmonary Fibrosis Registry for mutations in hTERT and hTR. Six probands (8%) had heterozygous mutations in hTERT or hTR; mutant telomerase resulted in short telomeres. Asymptomatic subjects with mutant telomerase also had short telomeres, suggesting that they may be at risk for the disease. We did not identify any of the classic features of dyskeratosis congenita in five of the six families. Mutations in the genes encoding telomerase components can appear as familial idiopathic pulmonary fibrosis. Our findings support the idea that pathways leading to telomere shortening are involved in the pathogenesis of this disease. Copyright 2007 Massachusetts Medical Society.
                Bookmark

                Author and article information

                Contributors
                varun.kumar@med.uni-heidelberg.de
                peter.nawroth@med.uni-heidelberg.de
                Journal
                EMBO J
                EMBO J
                10.1002/(ISSN)1460-2075
                EMBJ
                embojnl
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                0261-4189
                1460-2075
                27 April 2020
                02 June 2020
                27 April 2020
                : 39
                : 11 ( doiID: 10.1002/embj.v39.11 )
                : e103477
                Affiliations
                [ 1 ] Department of Medicine I and Clinical Chemistry University Hospital of Heidelberg Heidelberg Germany
                [ 2 ] European Molecular Biology Laboratory Advanced Light Microscopy Facility Heidelberg Germany
                [ 3 ] German Center for Diabetes Research (DZD) Heidelberg Germany
                [ 4 ] Department of Translational Pulmonology Translational Lung Research Center Heidelberg (TLRC) German Center for Lung Research (DZL) University of Heidelberg Heidelberg Germany
                [ 5 ] Hopp Children's Cancer Center Heidelberg Germany
                [ 6 ] Medical Faculty Heidelberg University Heidelberg Germany
                [ 7 ] Department of Biology University of Rochester Rochester NY USA
                [ 8 ] Department of Pediatric Pulmonology, Immunology and Critical Care Medicine Charité ‐ Universitätsmedizin Berlin Berlin Germany
                [ 9 ] Berlin Institute of Health (BIH) Berlin Germany
                [ 10 ] Institute for Diabetes and Cancer Helmholtz Center Munich Neuherberg Germany
                [ 11 ] Joint Heidelberg‐IDC Translational Diabetes Program Helmholtz‐Zentrum München Germany
                [ 12 ] Technical University Munich Munich Germany
                Author notes
                [*] [* ] Corresponding author: Tel: +49 6221 56 6960; E.mail: varun.kumar@ 123456med.uni-heidelberg.de

                Corresponding author: Tel: +49 6221 56 8601; E‐mail: peter.nawroth@ 123456med.uni-heidelberg.de

                Author information
                https://orcid.org/0000-0003-2827-1024
                https://orcid.org/0000-0003-3950-3652
                https://orcid.org/0000-0002-6134-7804
                Article
                EMBJ2019103477
                10.15252/embj.2019103477
                7265245
                32338774
                3fc8a4d5-a621-4d93-b75c-26d002402146
                © 2020 The Authors. Published under the terms of the CC BY 4.0 license

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 17 September 2019
                : 27 February 2020
                : 08 March 2020
                Page count
                Figures: 10, Tables: 0, Pages: 20, Words: 15867
                Funding
                Funded by: Deutsche Forschungsgemeinschaft (DFG) , open-funder-registry 10.13039/501100001659;
                Award ID: SFB1118
                Award ID: GRK 1874‐DIAMICOM
                Funded by: Helmholtz Cross Program Topic Metabolic Dysfunction
                Funded by: Foundation for Diabetes Research
                Categories
                Article
                Articles
                Custom metadata
                2.0
                02 June 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.3 mode:remove_FC converted:02.06.2020

                Molecular biology
                diabetes,dna double‐strand breaks,nuclear isoform of the receptor for advanced glycation end products,pulmonary fibrosis,reducing carbohydrates,dna replication, repair & recombination,metabolism,molecular biology of disease

                Comments

                Comment on this article